Edition:
United Kingdom

Coherus BioSciences Inc (CHRS.OQ)

CHRS.OQ on NASDAQ Stock Exchange Global Market

15.65USD
4:21pm BST
Change (% chg)

$0.15 (+0.97%)
Prev Close
$15.50
Open
$15.50
Day's High
$15.75
Day's Low
$15.25
Volume
20,286
Avg. Vol
170,052
52-wk High
$23.20
52-wk Low
$8.07

Chart for

About

Coherus BioSciences, Inc. is a late-stage clinical biologics platform company. The Company is engaged in the business of developing and commercializing biosimilar products. The Company's business is organized around therapeutic franchises, including Oncology biosimilar candidates pegfilgrastim (Neulasta) and bevacizumab... (more)

Overall

Beta: 3.49
Market Cap(Mil.): $975.55
Shares Outstanding(Mil.): 61.16
Dividend: --
Yield (%): --

Financials

  CHRS.OQ Industry Sector
P/E (TTM): -- 223.30 32.53
EPS (TTM): -0.63 -- --
ROI: -18.02 -8.07 12.63
ROE: -66.69 -10.87 14.50

BRIEF-Coherus BioSciences Re-Submits Biologics License Application For CHS-1701

* COHERUS BIOSCIENCES RE-SUBMITS BIOLOGICS LICENSE APPLICATION FOR CHS-1701 (PEGFILGRASTIM BIOSIMILAR CANDIDATE)

03 May 2018

BRIEF-Coherus Biosciences Says U.S. Court Grants Motion To Dismiss Patent Infringement Complaint

* COHERUS BIOSCIENCES-U.S. COURT ADOPTED MAGISTRATE JUDGE BURKE'S REPORT & RECOMMENDATION TO GRANT MOTION OF CO TO DISMISS PATENT INFRINGEMENT COMPLAINT

26 Mar 2018

BRIEF-Coherus BioSciences Reports Q4 Loss Per Share $0.84

* COHERUS BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

08 Mar 2018

BRIEF-Coherus Biosciences Says ‍Had Cash And Cash Equivalents Of About $126.9 Million

* COHERUS BIOSCIENCES SAYS ‍HAD CASH AND CASH EQUIVALENTS OF ABOUT $126.9 MILLION AS OF DEC 31 - SEC FILING​ Source text : (http://bit.ly/2qqVZLs) Further company coverage:

05 Jan 2018

BRIEF-Coherus Says Judge Issued Under Seal Report & Recommendation In Relation To Patent Infringement Complaint

* COHERUS SAYS U.S. JUDGE RECOMMENDED COURT GRANT CO'S PENDING MOTION TO DISMISS AMGEN'S COMPLAINT FOR FAILURE TO STATE CLAIM

08 Dec 2017

Competitors

  Price Chg
Amgen, Inc. (AMGN.OQ) $176.65 +0.35
Pfizer Inc. (PFE.N) $35.67 +0.03
Mylan NV (MYL.OQ) $39.97 +0.31
Teva Pharmaceutical Industries Limited (TEVA.TA) 7,582.00 +2.00
LG Chem Ltd (051910.KS) ₩338,500.00 -5,500.00
LG Chem Ltd (051915.KS) ₩203,500.00 -3,500.00
AbbVie Inc (ABBV.N) $106.53 +0.55
Momenta Pharmaceuticals, Inc. (MNTA.OQ) $23.35 -0.05
FUJIFILM Holdings Corp (4901.T) ¥4,360 +55.00

Earnings vs. Estimates